研究抗體和試劑市場規模、佔有率及成長分析（按類型、應用、研究領域、最終用戶、分銷管道和地區）－2025-2032 年產業預測

預計 2023 年全球研究抗體和試劑市場價值將達到 133 億美元，並從 2024 年的 142.2 億美元成長到 2032 年的 242.5 億美元，預測期內（2025-2032 年）的複合年成長率為 6.9%。

研究抗體和試劑市場正在崛起，這得益於對可重複研究至關重要的高品質抗體的需求不斷成長。關鍵成長要素包括蛋白質體學和基因組學的擴展、旨在改善診斷和治療結果的研發活動的活性化以及產學研合作的加強。此外，商業和非營利組織的投資增加、對生物標記發現的關注度增加以及政府的支持也在推動市場成長。向個人化醫療和蛋白質療法的轉變提供了進一步的有利可圖的機會。然而，耗時的抗體開發和定價壓力等挑戰，以及對品質和可重複性的新興擔憂，可能會阻礙進展，需要在預測期內解決。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

研究抗體和試劑市場規模（按類型和複合年成長率）（2025-2032）

• 市場概覽
• 抗體
  • 產品
  • 一抗
  • 二抗
  • 來源
  • 老鼠
  • 兔子
  • 山羊
  • 老鼠
  • 其他
  • 起源
  • 單株抗體
  • 多株抗體
  • 重組抗體
• 試劑
  • 緩衝液和溶液
  • PBS（磷酸鹽緩衝生理食鹽水）
  • 封閉緩衝液
  • 稀釋緩衝液
  • 清洗緩衝液
  • 化學冷光試劑

研究抗體和試劑市場規模（按應用和複合年成長率）（2025-2032）

• 市場概覽
• 酵素免疫分析法
• 蛋白質印跡法
• 免疫組織化學
• 流式細胞技術
• 聚合酵素鏈鎖反應
• 其他

研究抗體和試劑市場規模（按研究領域和複合年成長率）（2025-2032）

• 市場概覽
• 免疫學
• 細胞與分子生物學
• 神經科學
• 基因組學和蛋白​​質組學
• 生物技術與藥物研發
• 微生物學
• 其他

研究抗體和試劑市場規模（按最終用戶和複合年成長率分類）（2025-2032）

• 市場概覽
• 製藥和生物製藥製造商
• 學術研究所
• 合約研究組織（CRO）
• 醫院和診斷實驗室
• 其他

研究抗體和試劑市場規模（按分銷管道和複合年成長率）（2025-2032）

• 市場概覽
• 直銷
• 第三方銷售
• 其他

研究抗體和試劑市場規模（按地區及複合年成長率）（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Thermo Fisher Scientific, Inc.（USA）
• Merck KGaA（Germany）
• Danaher Corporation（USA）
• Bio-Rad Laboratories, Inc.（USA）
• Abcam plc（UK）
• Cell Signaling Technology, Inc.（USA）
• Bio-Techne Corporation（USA）
• F. Hoffmann-La Roche AG（Switzerland）
• Agilent Technologies, Inc.（USA）
• Illumina, Inc.（USA）
• Becton, Dickinson and Company（BD）（USA）
• Proteintech Group, Inc.（USA）
• Jackson Immuno Research Inc.（USA）
• GenScript Biotech Corporation（China）
• Lonza Group Ltd.（Switzerland）
• Santa Cruz Biotechnology, Inc.（USA）
• PerkinElmer, Inc.（USA）
• Revvity（USA）
• Atlas Antibodies AB（Sweden）
• SouthernBiotech（USA）

結論和建議

Global Research Antibodies and Reagents Market size was valued at USD 13.3 billion in 2023 and is poised to grow from USD 14.22 billion in 2024 to USD 24.25 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).

The research antibodies and reagents market is on an upward trajectory, driven by the growing demand for high-quality antibodies essential for reproducible research. Key growth factors include the expansion of proteomics and genomics, increased R&D activities aimed at enhancing diagnostic and therapeutic outcomes, and strengthened collaborations between industry and academia. Additionally, rising investments from both profit and non-profit organizations, a focus on biomarker discovery, and government support are bolstering market growth. The shift towards personalized medicine and protein therapeutics further presents lucrative opportunities. However, challenges such as the time-consuming nature of antibody development and pricing pressures may impede progress, alongside emerging concerns over quality and reproducibility that need to be addressed during the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Research Antibodies And Reagents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Research Antibodies And Reagents Market Segments Analysis

Global Research Antibodies and Reagents Market is segmented by Type, Application, Research Area, End User, Distribution Channel and region. Based on Type, the market is segmented into Antibodies and Reagents. Based on Application, the market is segmented into Enzyme-Linked Immunosorbent Assay, Western Blotting, Immunohistochemistry, Flow Cytometry, Polymerase Chain Reaction and Others. Based on Research Area, the market is segmented into Immunology, Cell & Molecular Biology, Neuroscience, Genomics & Proteomics, Biotechnology & Drug Discovery, Microbiology and Others. Based on End User, the market is segmented into Pharmaceutical and Biopharmaceutical Manufacturers, Academic And Research Institutes, Contract Research Organizations (CROs), Hospitals & Diagnostic Laboratories and Others. Based on Distribution Channel, the market is segmented into Direct Sales, Third Party Sales and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Research Antibodies And Reagents Market

The Global Research Antibodies and Reagents market is significantly influenced by the synergy between academic institutions and the research and development sectors of various businesses. This collaboration facilitates the transfer of knowledge and advancements in technology, enhancing innovation and research capabilities. As economic uncertainties rise and technological advancements accelerate, these partnerships have become increasingly prevalent. Market players are focusing on engaging with academic institutions to raise awareness among students and researchers about cutting-edge analytical technologies, reflecting the diverse applications of research-specific antibodies and reagents, which ultimately drives market growth and development.

Restraints in the Global Research Antibodies And Reagents Market

The Global Research Antibodies and Reagents market faces significant challenges due to the reproducibility crisis, which highlights the troubling realization that many findings in biomedical research fail to replicate, casting doubt on their validity. This issue primarily stems from inconsistencies in the quality of antibodies, largely arising from diverse production techniques. Furthermore, the absence of standardized definitions for reproducibility across antibody products and a lack of comprehensive validation standards exacerbate the problem. As a result, researchers encounter difficulties in obtaining reliable and consistent results, which can undermine trust in scientific conclusions drawn from these studies.

Market Trends of the Global Research Antibodies And Reagents Market

The Global Research Antibodies and Reagents market is poised for substantial growth as personalized medicine continues to revolutionize disease detection, categorization, and treatment-especially in oncology. With biopharmaceutical companies ramping up R&D investments in personalized medicine, projected to surge by 33% over the next five years, the demand for advanced antibodies and reagents is escalating. The need for rapid and highly sensitive techniques to analyze proteins and their post-translational modifications is critical for tailoring patient-specific therapies. Researchers are increasingly focusing on gene variants and their correlations with drug responses, underscoring the necessity for innovative tools in this evolving healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Research Antibodies and Reagents Market Size by Type & CAGR (2025-2032)

• Market Overview
• Antibodies
  • Products
  • Primary Antibodies
  • Secondary Antibodies
  • Source
  • Mouse
  • Rabbit
  • Goat
  • Rat
  • Others
  • Origin
  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Antibodies
• Reagents
  • Buffers & Solution
  • PBS (Phosphate Buffered Saline)
  • Blocking Buffers
  • Dilution Buffers
  • Wash Buffers
  • Chemiluminescent Reagents

Global Research Antibodies and Reagents Market Size by Application & CAGR (2025-2032)

• Market Overview
• Enzyme-Linked Immunosorbent Assay
• Western Blotting
• Immunohistochemistry
• Flow Cytometry
• Polymerase Chain Reaction
• Others

Global Research Antibodies and Reagents Market Size by Research Area & CAGR (2025-2032)

• Market Overview
• Immunology
• Cell & Molecular Biology
• Neuroscience
• Genomics & Proteomics
• Biotechnology & Drug Discovery
• Microbiology
• Others

Global Research Antibodies and Reagents Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical and Biopharmaceutical Manufacturers
• Academic And Research Institutes
• Contract Research Organizations (CROs)
• Hospitals & Diagnostic Laboratories
• Others

Global Research Antibodies and Reagents Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Direct Sales
• Third Party Sales
• Others

Global Research Antibodies and Reagents Market Size & CAGR (2025-2032)

• North America (Type, Application, Research Area, End User, Distribution Channel)
  • US
  • Canada
• Europe (Type, Application, Research Area, End User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application, Research Area, End User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application, Research Area, End User, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, Research Area, End User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proteintech Group, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jackson Immuno Research Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Santa Cruz Biotechnology, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Atlas Antibodies AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SouthernBiotech (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations